Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 114,011 | 81,467 | 93,282 | 104,735 | 332,798 |
| Marketable Securities | 95,957 | 211,474 | 265,065 | 333,605 | 154,233 |
| Receivables | 11,915 | 15,868 | 12,399 | 11,413 | 15,414 |
| Other current assets | 61,151 | 74,173 | 69,670 | 35,509 | 26,282 |
| TOTAL | $293,071 | $393,341 | $450,724 | $498,386 | $534,218 |
| Non-Current Assets | |||||
| PPE Net | 16,944 | 16,422 | 15,430 | 14,433 | 13,905 |
| Investments And Advances | 19,439 | 12,750 | 0 | 0 | 5,067 |
| Other Non-Current Assets | 45,654 | 46,544 | 46,034 | 51,511 | 52,219 |
| TOTAL | $82,037 | $75,716 | $61,464 | $65,944 | $71,191 |
| Total Assets | $375,108 | $469,057 | $512,188 | $564,330 | $605,409 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,659 | 19,334 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 6,834 | 6,775 | 6,442 | 10,065 | 6,645 |
| Accrued Expenses | 26,382 | 45,260 | 36,263 | 30,459 | 31,031 |
| TOTAL | $86,492 | $123,571 | $104,270 | $106,574 | $98,040 |
| Non-Current Liabilities | |||||
| Long Term Debt | 375,181 | 372,873 | 384,482 | 375,266 | 373,854 |
| Deferred Revenues | 7,661 | 11,523 | 18,204 | 25,062 | 23,193 |
| Other Non-Current Liabilities | 286,314 | 276,016 | 284,222 | 283,672 | 282,940 |
| TOTAL | $661,834 | $649,237 | $669,454 | $660,092 | $665,305 |
| Total Liabilities | $748,326 | $772,808 | $773,724 | $766,666 | $763,345 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 65,279 | 64,328 | 63,981 | 63,515 | 63,088 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -1,606,296 | -1,526,617 | -1,468,183 | -1,394,540 | -1,331,653 |
| Other shareholders' equity | 17 | 47 | 122 | 280 | 512 |
| TOTAL | $-373,218 | $-303,751 | $-261,536 | $-202,336 | $-157,936 |
| Total Liabilities And Equity | $375,108 | $469,057 | $512,188 | $564,330 | $605,409 |